首页 > 市场调查报告书 > 製药

动物用医药

市场调查报告书

商品编码

1578273

全球动物药物復配市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Animal Drug Compounding Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到2032年，全球动物药物復配市场的市场规模将从2023年的19.8亿美元达到近42.1亿美元，2024-2032年研究期间的复合年增长率为8.73%。

动物药物配製是巩固、混合或修改混合物以根据单一动物或一小群动物的需要定製药物的过程。通常由药剂师或兽医製作。动物药物配製不需要 FDA 批准来证明安全性和有效性，除非配製原料或活性成分是 FDA 批准的药物。用压碎的片剂製备口服糊剂或悬浮液、混合两种注射药物或在药物中添加调味剂是动物药物配製的典型例子。

市场动态

已开发国家和发展中国家动物疾病负担的增加、宠物人性化的增加以及动物收养的增加可能会推动全球动物药物复合市场的发展。品牌处方药的成本不断增加、药品的可及性不足以及网路上医疗资讯的不断涌入是促进市场成长的其他因素。主要市场参与者致力于透过提供替代兽医复合解决方案来扩大其产品组合，以满足动物的所需需求。主要公司也与咨询兽医合作，提供有关常见化合物的最新资讯。然而，对安全性、品质和有效性的担忧以及缺乏训练有素的熟练医疗专业人员是限制动物药物复合需求的因素。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球动物药物复合市场的每个细分市场进行了包容性评估。动物药物配製产业的成长和趋势为本研究提供了整体方法。

市场区隔

动物药物复合市场报告的这一部分提供了国家和区域层面的细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依动物类型

伴侣动物（狗、猫等）
畜牧动物

按产品分类

抗感染剂
抗发炎剂
荷尔蒙及替代品
中枢神经系统药剂
其他的

依给药途径

口服
可注射
专题
其他的

依剂型分类

暂停
解决方案
胶囊

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲动物药物复合市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。动物药物配製市场的主要参与者包括 Wedgewood Pharmacy、Vimian、Pharmaca.、Akina Animal Health、Triangle Blending.、DavisIslands Pharmacy And Blending Lab、Custom Med Complexing Pharmacy、Central Complexing Center South.、Wellness Pharmacy Of Cary.、米勒药房。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按动物类型分類的市场吸引力分析
- 按产品分類的市场吸引力分析
- 按给药途径进行的市场吸引力分析
- 按剂型分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球动物药物复方市场分析：依动物类型

依动物类型概述
按动物类型的历史和预测数据分析
伴侣动物（狗、猫等）
畜牧动物

第 6 章：全球动物药物复方市场分析：依产品分类

概述（按产品）
按产品分类的历史和预测资料分析
抗感染剂
抗发炎剂
荷尔蒙及替代品
中枢神经系统药剂
其他的

第 7 章：全球动物药物复方市场分析：依给药途径

依给药途径概述
按给药途径进行历史和预测资料分析
口服
可注射
专题
其他的

第 8 章：全球动物药物复方市场分析：按剂型

按剂型概述
按剂型进行历史和预测数据分析
暂停
解决方案
胶囊

第 9 章：全球动物药物复方市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：动物药复方公司的竞争格局

兽药復配市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Wedgewood Pharmacy

公司概况
公司收入
产品
最新动态

Vimian

公司概况
公司收入
产品
最新动态

Pharmaca.

公司概况
公司收入
产品
最新动态

Akina Animal Health

公司概况
公司收入
产品
最新动态

Triangle Compounding.

公司概况
公司收入
产品
最新动态

Davis Islands Pharmacy And Compounding Lab

公司概况
公司收入
产品
最新动态

Custom Med Compounding Pharmacy

公司概况
公司收入
产品
最新动态

Central Compounding Center South.

公司概况
公司收入
产品
最新动态

Wellness Pharmacy Of Cary.

公司概况
公司收入
产品
最新动态

Miller'S Pharmacy

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215051

The global demand for Animal Drug Compounding Market is presumed to reach the market size of nearly USD 4.21 Billion by 2032 from USD 1.98 Billion in 2023 with a CAGR of 8.73% under the study period 2024-2032.

Animal drug compounding is the process of consolidating, blending or modifying mixtures to make a medication customized to the needs of an individual animal or a small group of animals. Pharmacists or veterinarians typically make them. Animal drug compounding does not require FDA approval to demonstrate safety and efficiency unless compounding raw material or active ingredient is an FDA-approved drug. Preparing an oral paste or suspension from crushed tablets, mixing two injectable medications, or adding flavoring to a drug are typical examples of animal drug compounding.

MARKET DYNAMICS

Spurring animal disease burden, increased humanization of pets, and rising adoption of animals in developed and developing nations are likely to boost the global animal drug compounding market. The increasing cost of branded prescription equivalents, inadequate accessibility to drugs, and the growing influx of medical information over the internet are other factors augmenting the market growth. Key market players are focused on expanding their portfolios by delivering substitute vet compounding solutions to meet the desired needs of animals. Key companies are also consolidating with consulting veterinarians to provide up-to-date information about common compounds. However, concerns about safety, quality, and effectiveness and the absence or lack of trained and skilled medical professionals are factors restraining demand for animal drug compounding.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Animal Drug Compounding. The growth and trends of Animal Drug Compounding industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Animal Drug Compounding market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Type

Companion Animals (Dogs, Cats, Others)
Livestock Animals

By Product

Anti-Infective Agents
Anti-Inflammatory Agents
Hormones & Substitutes
CNS Agents
Others

By Route of Administration

Oral
Injectable
Topical
Others

By Dosage Form

Suspensions
Solutions
Capsules

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Animal Drug Compounding market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Animal Drug Compounding market include Wedgewood Pharmacy, Vimian, Pharmaca., Akina Animal Health, Triangle Compounding., Davis Islands Pharmacy And Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South., Wellness Pharmacy Of Cary., Miller'S Pharmacy. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANIMAL DRUG COMPOUNDING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Animal Type
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Route of Administration
- 3.7.4 Market Attractiveness Analysis By Dosage Form
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY ANIMAL TYPE

5.1. Overview By Animal Type
5.2. Historical and Forecast Data Analysis By Animal Type
5.3. Companion Animals (Dogs, Cats, Others) Historic and Forecast Sales By Regions
5.4. Livestock Animals Historic and Forecast Sales By Regions

6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Anti-Infective Agents Historic and Forecast Sales By Regions
6.4. Anti-Inflammatory Agents Historic and Forecast Sales By Regions
6.5. Hormones & Substitutes Historic and Forecast Sales By Regions
6.6. CNS Agents Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1. Overview By Route of Administration
7.2. Historical and Forecast Data Analysis By Route of Administration
7.3. Oral Historic and Forecast Sales By Regions
7.4. Injectable Historic and Forecast Sales By Regions
7.5. Topical Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY DOSAGE FORM

8.1. Overview By Dosage Form
8.2. Historical and Forecast Data Analysis By Dosage Form
8.3. Suspensions Historic and Forecast Sales By Regions
8.4. Solutions Historic and Forecast Sales By Regions
8.5. Capsules Historic and Forecast Sales By Regions

9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANIMAL DRUG COMPOUNDING COMPANIES

10.1. Animal Drug Compounding Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF ANIMAL DRUG COMPOUNDING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Wedgewood Pharmacy
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Vimian
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Pharmaca.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Akina Animal Health
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Triangle Compounding.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Davis Islands Pharmacy And Compounding Lab
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Custom Med Compounding Pharmacy
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Central Compounding Center South.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Wellness Pharmacy Of Cary.
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Miller'S Pharmacy
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments